Is BRTX or CADL more undervalued in 2026?

CirclFi compares BioRestorative Therapies, Inc. (BRTX) and Candel Therapeutics, Inc. (CADL) using 13 institutional-grade valuation models. BRTX has a Quality of Company score of 5.5/10 while CADL scores 4.4/10.

Which is a better buy — BRTX or CADL?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BRTX and CADL valuations compare?

BRTX at $0.48 and CADL at $8.09 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BRTX vs CADL Valuation Comparison 2026 — Intrinsic Value Analysis

BRTX

Biotechnology

BioRestorative Therapies, Inc.

Quality

5.5

out of 10

Value Trap

LOW

Price

$0.48

Last close

Models

11/13

Active

CADL

Biotechnology

Candel Therapeutics, Inc.

Quality

4.4

out of 10

Value Trap

LOW

Price

$8.09

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	BRTX Fair Value	BRTX Upside	CADL Fair Value	CADL Upside
Bayesian DCF	Intrinsic	$0.20	-59.3%	$3.35	-58.6%
Earnings Power Value	Intrinsic	$0.14	-39.2%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.70	+45.9%	$2.44	-69.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BRTX vs CADL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BRTX vs CADL — Which Stock Is More Undervalued?

BRTX scores higher with a 5.5/10 quality rating vs CADL's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BioRestorative Therapies, Inc. (BRTX) and Candel Therapeutics, Inc. (CADL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BRTX currently trades at $0.48 with a QOC of 5.5/10, while CADL trades at $8.09 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).